Clinical Trials
9 trialsNCT03721068 2026-03-27
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
UNC Lineberger Comprehensive Cancer Center
Phase 1 Recruiting
NCT05992532 2026-02-11
GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma
Fundación Española de Hematología y Hemoterapía
Recruiting
NCT06573723 2026-01-14
Institutional Registry of Rare Diseases
Hospital Italiano de Buenos Aires
Recruiting
NCT05687474 2025-08-12
BabyDetect
Centre Hospitalier Universitaire de Liege
Completed
NCT06539169 2024-11-14
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
xCures
Recruiting
NCT01586455 2022-10-25
HPDSC
New York Medical College
Phase 1 Completed
NCT04637503 2020-11-19
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Unknown
NCT01417520 2019-07-26
Clinical and Pathophysiological Investigations Into Erdheim Chester Disease
National Institutes of Health Clinical Center (CC)
Completed
NCT00005900 2005-06-24
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Office of Rare Diseases (ORD)
Unknown